Opportunity Information: Apply for CDC RFA PS21 21030301SUPP23
The Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement is a CDC supplemental cooperative agreement opportunity from the Department of Health and Human Services (CDC, NCHHSTP). It is designed specifically for organizations that already received awards under the earlier Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments program (CDC-RFA-PS21-2103). In other words, this is not a brand-new standalone competition for first-time applicants; it is additional funding meant to expand or strengthen work that is already underway through the existing IVHSP award.
The supplement focuses on two closely related public health priorities. First, it aims to improve early detection of hepatitis C (HCV) outbreaks and transmission clusters and help health departments interrupt transmission more quickly. Second, it seeks to increase hepatitis B (HBV) and hepatitis C diagnosis and treatment by expanding routine testing and improving linkage to prevention and treatment services in settings that see a high burden of infection or high risk of exposure. The overall intent is to move from finding infections late to identifying patterns earlier, responding faster, and connecting more people to care in places where missed opportunities are common.
Applicants can apply for one or both of the two components included in the supplemental notice of funding opportunity. Component 1, titled Integrating Genomic and Epidemiologic Surveillance for Outbreak Detection and Response, supports work to build or enhance an integrated surveillance approach for HCV. The core idea is to combine traditional epidemiologic information (case investigations, risk data, time and place patterns, networks, and other public health surveillance elements) with molecular or genomic information so that health departments can better identify related infections. By using both types of data together, programs are better positioned to detect transmission clusters and outbreaks that might not be obvious through routine reporting alone, and then take public health action based on that intelligence.
Component 2, titled Increasing Access to Hepatitis C and/or Hepatitis B Testing and Linkage to Care in High-Impact Settings, supports expanded testing and stronger linkage-to-care efforts for HBV and/or HCV in settings where transmission risk is elevated or where underserved populations are more likely to seek services. The notice highlights examples of these high-impact settings, including syringe services programs, substance use disorder treatment centers, correctional facilities, emergency departments, and sexually transmitted infection clinics. The practical emphasis is on conducting testing in these venues and ensuring that people who test positive are connected to prevention services and medical evaluation and treatment, rather than being lost to follow-up.
Administratively, this opportunity is categorized as a discretionary grant using a cooperative agreement funding instrument, which typically means CDC expects substantial involvement in the project beyond routine grant monitoring. The CFDA number listed is 93.270. The opportunity number is CDC RFA PS21 21030301SUPP23, and the posting indicates an expected 10 awards. The original application closing date was March 20, 2023, with applications due electronically by 11:59 pm Eastern Time on the deadline. The award ceiling is shown as 0 in the source data, which usually indicates the ceiling was not specified in that field rather than implying no funding. Eligibility is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," but the description makes clear the target applicants are those already funded under the earlier IVHSP award.Apply for CDC RFA PS21 21030301SUPP23
- The Department of Health and Human Services, Centers for Disease Control - NCHHSTP in the health sector is offering a public funding opportunity titled "Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.270.
- This funding opportunity was created on Feb 03, 2023.
- Applicants must submit their applications by Mar 20, 2023 Electronically submitted applications must be submitted no later than 1159 pm ET on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is this funding opportunity?
The Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement is a CDC supplemental cooperative agreement opportunity from the U.S. Department of Health and Human Services (CDC, NCHHSTP). It provides additional funding intended to expand or strengthen work already being conducted under the earlier Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments program (CDC-RFA-PS21-2103).
2) Is this a new standalone grant competition for first-time applicants?
No. This is a supplement designed specifically for organizations that already received awards under the earlier IVHSP program (CDC-RFA-PS21-2103). It is described as additional funding for existing awardees rather than a brand-new, standalone competition for new applicants.
3) Which agency is offering this supplement?
The opportunity is offered by the Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services, specifically through NCHHSTP.
4) What are the main public health priorities of the supplement?
The supplement emphasizes two closely related priorities: (1) improving early detection of hepatitis C (HCV) outbreaks and transmission clusters so health departments can interrupt transmission faster, and (2) increasing hepatitis B (HBV) and hepatitis C diagnosis and treatment by expanding routine testing and strengthening linkage to prevention and treatment services in high-burden or high-risk settings.
5) What is the overall intent of the supplement?
The overall intent is to shift from detecting infections late to identifying patterns earlier, responding more quickly, and connecting more people to prevention services, medical evaluation, and treatment in places where missed opportunities are common.
6) Are there multiple components, and can an applicant apply to more than one?
Yes. The supplemental notice includes two components, and applicants may apply for one or both components.
7) What is Component 1?
Component 1 is titled "Integrating Genomic and Epidemiologic Surveillance for Outbreak Detection and Response." It supports work to build or enhance an integrated surveillance approach for HCV by combining traditional epidemiologic information with molecular or genomic information to better identify related infections, detect transmission clusters and outbreaks, and take public health action.
8) What kinds of data does Component 1 integrate?
Component 1 focuses on integrating traditional epidemiologic information (such as case investigations, risk data, time and place patterns, networks, and other public health surveillance elements) with molecular or genomic information to improve detection of related infections and transmission patterns.
9) Why does Component 1 emphasize genomic and epidemiologic integration?
By using both epidemiologic and molecular/genomic information together, programs may be better positioned to detect transmission clusters and outbreaks that might not be obvious through routine reporting alone, and then respond using that combined intelligence.
10) What is Component 2?
Component 2 is titled "Increasing Access to Hepatitis C and/or Hepatitis B Testing and Linkage to Care in High-Impact Settings." It supports expanded testing and improved linkage-to-care efforts for HBV and/or HCV in settings where transmission risk is elevated or where underserved populations are more likely to seek services.
11) Does Component 2 support HBV, HCV, or both?
Component 2 supports increasing access to hepatitis C and/or hepatitis B testing and linkage to care. In other words, it can involve HCV, HBV, or both, based on what is proposed.
12) What are examples of "high-impact settings" mentioned for Component 2?
The notice provides examples that include syringe services programs, substance use disorder treatment centers, correctional facilities, emergency departments, and sexually transmitted infection clinics.
13) What is the practical emphasis of Component 2 in these settings?
The practical emphasis is on conducting testing in the identified venues and ensuring that people who test positive are connected to prevention services and medical evaluation and treatment, rather than being lost to follow-up.
14) What type of award is this (grant vs. cooperative agreement)?
This opportunity is a discretionary grant using a cooperative agreement funding instrument.
15) What does it mean that the funding instrument is a cooperative agreement?
A cooperative agreement typically indicates CDC expects substantial involvement in the project beyond routine grant monitoring, as described in the opportunity summary.
16) What is the CFDA number for this opportunity?
The CFDA number listed is 93.270.
17) What is the opportunity number?
The opportunity number is CDC RFA PS21 21030301SUPP23.
18) How many awards were expected?
The posting indicates an expected 10 awards.
19) When was the application deadline?
The original application closing date was March 20, 2023, with applications due electronically by 11:59 pm Eastern Time on the deadline.
20) How were applications submitted?
Applications were due electronically by 11:59 pm Eastern Time on the deadline date listed.
21) Is there an award ceiling listed?
The award ceiling is shown as 0 in the source data. The description notes this typically indicates the ceiling was not specified in that field, rather than implying there was no funding.
22) Who is eligible to apply?
Eligibility is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)." However, the description makes clear the intended applicants are organizations that already received awards under the earlier Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments program (CDC-RFA-PS21-2103).
23) Is this supplement focused more on surveillance, services, or both?
Both. Component 1 focuses on enhancing HCV outbreak/cluster detection and response through integrated genomic and epidemiologic surveillance. Component 2 focuses on expanding HBV/HCV testing and improving linkage to prevention and treatment services in high-impact settings.
24) What hepatitis viruses are addressed by this supplement?
The supplement addresses hepatitis C (HCV) and hepatitis B (HBV). Component 1 is focused on HCV surveillance integration for outbreak detection and response, while Component 2 supports HBV and/or HCV testing and linkage to care.
25) What outcomes is the supplement trying to improve?
Based on the description, the supplement is designed to improve early detection of HCV outbreaks and clusters, speed interruption of transmission, increase HBV/HCV diagnosis and treatment, expand routine testing, and strengthen linkage to prevention services and medical evaluation/treatment, particularly in high-impact settings.
Browse more opportunities from the same category: Health
Next opportunity: BJA FY 23 Comprehensive Opioid, Stimulant, and Substance Use Program Training and Technical Assistance
Previous opportunity: Hospital-based Quality Improvement Collaborative to Improve Maternity Care Practices Supportive of Breastfeeding
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS21 21030301SUPP23
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS21 21030301SUPP23) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing Violence Epidemiology in Real-Time (AVERT) Apply for CDC RFA CE 23 0007 Funding Number: CDC RFA CE 23 0007 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $150,000 |
| RFI: USAID Local Solutions to Health Priorities in Indonesia (LSHP) Apply for 72049723RFI00002 Funding Number: 72049723RFI00002 Agency: Agency for International Development, Indonesia USAID-Jakarta Category: Health Funding Amount: $25,000,000 |
| Center of Excellence for Protected Health Information Related to Behavioral Health Apply for TI 23 013 Funding Number: TI 23 013 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $1,000,000 |
| Immunization Barriers in the United States: Targeting Medicaid Partnerships Apply for CDC RFA IP 23 0002 Funding Number: CDC RFA IP 23 0002 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Assertive Community Treatment (ACT) Grant Program Apply for SM 23 007 Funding Number: SM 23 007 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $678,000 |
| Racial and Ethnic Approaches to Community Health (REACH) Apply for CDC RFA DP 23 0014 Funding Number: CDC RFA DP 23 0014 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $1,500,000 |
| Pregnant People-Infant Linked Longitudinal Surveillance Apply for CDC RFA DD 23 0003 Funding Number: CDC RFA DD 23 0003 Agency: Department of Health and Human Services, Centers for Disease Control - NCBDDD Category: Health Funding Amount: Case Dependent |
| Sickle Cell Data Collection Program Apply for CDC RFA DD 23 0002 Funding Number: CDC RFA DD 23 0002 Agency: Department of Health and Human Services, Centers for Disease Control - NCBDDD Category: Health Funding Amount: $600,000 |
| U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) Small Grants Program Apply for DOS PSGP FY23 001 Funding Number: DOS PSGP FY23 001 Agency: Department of State, U.S. Mission to Malawi Category: Health Funding Amount: $10,000 |
| Fiscal Year 2023 Early Childhood Development Apply for HRSA 23 028 Funding Number: HRSA 23 028 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Advanced Nursing Education Nurse Practitioner Residency and Fellowship (ANE-NPRF) Program Apply for HRSA 23 009 Funding Number: HRSA 23 009 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Military Health System Research (MHSR) Apply for 24 DHA MHSR Funding Number: 24 DHA MHSR Agency: Department of Defense, Defense Health Agency Category: Health Funding Amount: $10,000,000 |
| Preventing HIV for Sustained Epidemic Control (PREVENT) Activity. Apply for 72061323RFA00003 Funding Number: 72061323RFA00003 Agency: Agency for International Development, Zimbabwe USAID-Harare Category: Health Funding Amount: $88,000,000 |
| Advancing Equity in Adolescent Health through Evidence-Based Teen Pregnancy Prevention Programs and Services Apply for AH TP1 23 001 Funding Number: AH TP1 23 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $2,000,000 |
| Advanced Nursing Education Workforce (ANEW) Program Apply for HRSA 23 014 Funding Number: HRSA 23 014 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $650,000 |
| Building capacity for implementing evidence-based epilepsy self-management supports in health care settings Apply for CDC RFA DP 23 0007 Funding Number: CDC RFA DP 23 0007 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $450,000 |
| Creating Safer States by Advancing Health Equity, Injury, and Violence Prevention Apply for CDC RFA CE 23 2308 Funding Number: CDC RFA CE 23 2308 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $10,000,000 |
| LOCAL HEALTH SYSTEMS SOLUTIONS (LHESS) ACTIVITY Apply for RFI 669 LHESS LIBERIA 2023 Funding Number: RFI 669 LHESS LIBERIA 2023 Agency: Agency for International Development, Liberia USAID-Monrovia Category: Health Funding Amount: $24,000,000 |
| Zero Suicide Initiative Coordinating Center Apply for HHS 2023 IHS ZSICC 0001 Funding Number: HHS 2023 IHS ZSICC 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $850,000 |
| Support Technical Assistance & Opportunities for Program, Policy, & Communications to Prevent STDs (STOP STDs) Apply for CDC RFA PS 23 0007 Funding Number: CDC RFA PS 23 0007 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS21 21030301SUPP23", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.